Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 CAD | -.--% |
|
-21.43% | -15.38% |
Chart calendar RepliCel Life Sciences Inc.
Upcoming events on RepliCel Life Sciences Inc.
Past events on RepliCel Life Sciences Inc.
2024-05-16 10:32 pm | Q4 2023 Earnings Release |
2023-10-23 07:04 pm | Q2 2023 Earnings Release |
2023-09-22 05:00 pm | Annual General Meeting |
2023-05-30 02:42 pm | Q1 2023 Earnings Release |
2023-05-01 05:58 pm | Q4 2022 Earnings Release |
2023-02-27 | Annual General Meeting |
2022-11-29 03:21 pm | Q3 2022 Earnings Release |
2022-10-31 02:00 pm | Extraordinary Shareholders Meeting |
2022-08-29 05:55 pm | Interim 2022 Earnings Release |
2022-07-06 06:48 pm | Q1 2022 Earnings Release |
2022-06-28 05:51 pm | FY 2021 Earnings Release |
2021-11-29 07:33 pm | Q3 2021 Earnings Release |
2021-08-30 03:19 pm | Interim 2021 Earnings Release |
2021-05-31 09:42 pm | Q1 2021 Earnings Release |
2021-04-30 05:24 pm | FY 2020 Earnings Release |
2020-12-08 07:30 pm | Annual General Meeting |
2020-11-30 05:13 pm | Q3 2020 Earnings Release |
2020-10-15 05:02 pm | Interim 2020 Earnings Release |
2020-07-29 | FY 2019 Earnings Release |
2019-12-17 | Annual General Meeting |
Past sector events for RepliCel Life Sciences Inc.
2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- REPCF Stock
- RP Stock
- Calendar RepliCel Life Sciences Inc.